Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.

Autor: Dinnon KH 3rd; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Edwards CE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Martinez DR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Montgomery SA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA., West A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Yount BL Jr; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Adams LE; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gully KL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Brown AJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Huang E; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bryant MD; Eiger BioPharmaceuticals, Palo Alto, CA, USA., Choong IC; Eiger BioPharmaceuticals, Palo Alto, CA, USA., Glenn JS; Departments of Medicine and Microbiology and Immunology, Stanford University, Stanford, CA, USA.; Palo Alto Veterans Administration, Palo Alto, CA, USA., Gralinski LE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Baric RS; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.; Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill, NC, USA. rbaric@email.unc.edu.

Publikováno v: Nature [Nature] 2021 Feb; Vol. 590 (7844), pp. E22.

A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures.

Autor: Dinnon KH, Leist SR, Schäfer A, Edwards CE, Martinez DR, Montgomery SA, West A, Yount BL, Hou YJ, Adams LE, Gully KL, Brown AJ, Huang E, Bryant MD, Choong IC, Glenn JS, Gralinski LE, Sheahan TP, Baric RS

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2020 May 07. Date of Electronic Publication: 2020 May 07.